⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDCX News
Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
accessnewswire.com
MDCX
MDCX
Three Biotech Companies Redefining Value Creation Through Dual Strategies
accessnewswire.com
MDCX
COEP
QNTM
The Vanderbilt Report: Medicus Pharma Ltd Built Three Separate Billion-Dollar Bets
accessnewswire.com
MDCX
MDCX
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
accessnewswire.com
MDCX
MDCX
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
accessnewswire.com
MDCX
MDCX
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
accessnewswire.com
MDCX
MDCX
Medicus Pharma Ltd. To Present at Brookline Capital Markets
accessnewswire.com
MDCX
MDCX
Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing
accessnewswire.com
MDCX
MDCX
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
accessnewswire.com
MDCX
MDCX